This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Rheumatology

18
Still no effective treatment for patients with CLE
Still no effective treatment for patients with CLE
Read more
Hydroxychloroquine not protective in those with SLE
Hydroxychloroquine not protective in those with SLE
Read more
Worsening of disease in those with spondyloarthritis during the COVID-19 lockdown
Worsening of disease in those with spondyloarthritis during the COVID-19 lockdown
Read more
JAK inhibitors: a major advance in the treatment of atopic eczema
JAK inhibitors: a major advance in the treatment of atopic eczema
Read more
IL-17 a potential therapeutic target in chronic urticaria
IL-17 a potential therapeutic target in chronic urticaria
Read more
Commentary: Increased risk of herpes zoster in patients prescribed JAK inhibitors
Commentary: Increased risk of herpes zoster in patients prescribed JAK inhibitors
Read more
Rheumatological autoimmune and inflammatory disorders: rapid guideline summary
Rheumatological autoimmune and inflammatory disorders: rapid guideline summary
Read more
Expert view: 2019 update of EULAR recommendations for the management of SLE
Expert view: 2019 update of EULAR recommendations for the management of SLE
Read more
Study finds molecule in lymphatic system implicated in autoimmune diseases
Study finds molecule in lymphatic system implicated in autoimmune diseases
Read more
Expert view: EULAR recommendations for management of APS
Expert view: EULAR recommendations for management of APS
Read more
Half of lupus rashes harbour high levels of bacteria responsible for infections
Half of lupus rashes harbour high levels of bacteria responsible for infections
Read more
A step closer to tailored treatment of severe rheumatic diseases
A step closer to tailored treatment of severe rheumatic diseases
Read more
Where next for dupilumab?
Where next for dupilumab?
Read more
Research offers new hope for the treatment of lupus
Research offers new hope for the treatment of lupus
Read more
Novel cancer therapy leads to insights into lupus
Novel cancer therapy leads to insights into lupus
Read more
Tofacitinib decreases gut leakiness associated with ulcerative colitis
Tofacitinib decreases gut leakiness associated with ulcerative colitis
Read more
New classification criteria for IgG4-related disease released
New classification criteria for IgG4-related disease released
Read more
Thermal cameras effective in detecting rheumatoid arthritis
Thermal cameras effective in detecting rheumatoid arthritis
Read more

Popular articles

Redefining management of uveal melanoma liver metastases: what oncologists need to know
Diagnostic AI tool ‘more accurate’ than physicians aims to ‘reshape’ healthcare
Be alert to Guillain-Barré risk after RSV vaccination in older adults, says MHRA
Forgo radioiodine ablation after thyroidectomy in low-risk cancer patients, say researchers
P2Y12 inhibitor monotherapy has lower MACCE risk than aspirin after PCI, study finds



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x